Evaluation of efficacy of anti-allergic ophthalmic solution for allergic conjunctival diseases using the allergic conjunctival disease medical treatment assessment system. - Evaluation of efficacy of anti-allergic ophthalmic solution for allergic conjunctival diseases.

Division of Ophthalmology, Department of Visual Sciences, Nihon University School of Medicine.0 个研究点目标入组 60 人开始时间: 2014年2月16日最近更新: 2023年10月17日

试验速览

暂无简介。

•1) Patients with anterior segment disease (including blepharitis, lagophthalmos, blepharospasm, iritis and conjunctivochalasis) other than allergic conjunctival diseases at the study initiation. 2) Patients who cannot discontinue eye drops (include all eye drops such as prescribed drug and OTC medicine) except for the study drug or the control drug from the study initiation until the end of study treatment or who expect to use those drugs 3) Patients with a history of surgery of the ocular surface within 12 months or patients with a history of intraocular surgery within three months prior to the study drug initiation examination. 4) Patients who have difficulty in sampling. 5) Patients that a study supervisor or a study partaker judged participation in this study to be inappropriate

发起方

Division of Ophthalmology, Department of Visual Sciences, Nihon University School of Medicine.